Welcome to the 2O13 ISMICSScientific Meeting

Science Amidst the Historical and Beautiful

2013 ANNUAL MEETING 12-15 June HILTON PRAGUE, CZECH REPUBLIC

INSIDE THIS ISSUE

ISMICS Masters Day - Wednesday

Robotic Revascularization

Off Pump Surgery

Atrial Fibrillation

Minimally Invasive Valve Surgery

Transcatheter Valves

Joint ISMICS/EACTC Course:Thoracic Robotic Surgery

Technical Challenges:Pitfalls and Disasters

2013 ConsensusConference:OPCAB/Off Pump Surgery

From the ISMICS Executive Director

2013 Exhibitors & Product Descriptions

2013 Industry Sponsors

Industry Sponsored Symposia

Poster Competition

INSIDE THIS ISSUE

DON’T MISSPRESIDENTIAL ADDRESS

Thursday, 11.00 – 11.45

Don’t Miss

the live

issue of the

ISMICS

Insider,

available on

Friday.

This issue will include coverage of

Wednesday’s Master Classes,

Thoracic and Cardiac track

presentations, the President’s

Address, poster competition and

more!

(continued on page 14)

Alan H. Menkis, MD, FRCSC

The 2012 ISMICS Annual Meeting Scientific Program has beendesigned to cover all aspects of minimally invasive and innovativesurgery and to present the latest scientific developments andinnovative techniques across the broad spectrum of minimallyinvasive CT surgery.

In addition to the Masters Day programs, keynote speakers,mini presentations, videos, and panel discussions, the programfeatures two distinct tracks – cardiac and thoracic – offeredsimultaneously on Thursday, Friday and Saturday. Each track willfocus on the state-of-the-art in each discipline and will includepresentations and discussions by the current experts in theirrespective fields.

There will also be industry sponsored breakfast and lunchsymposia, as well as ample opportunities to meet and greet yourcolleagues and friends.

Social programs and receptions will take full advantage of thisbeautiful city and we invite you to explore Prague and enjoy thescientific sessions.

Welcome to Prague and the ISMICSAnnual Meeting! We are very thankfulthat the timing of our annual meeting didnot coincide with the recent floods andthat life in Prague is now returning tonormal. A week ago, the city wasexperiencing record rainfall, the waters ofthe Vltava River were cresting and a stateof emergency was declared in the CzechRepublic.

We are grateful that the waters havereceded, the anti-flood barriers through-out the city have protected the city, andthe historical centre is intact for ourannual meeting. I hope that you will takethe opportunity to visit this wonderful cityand experience its unique and ancienttraditions. From the Prague castle,originally the residence of princes andkings of Bohemia, to Stromovka Park,once a royal hunting park, now a beautifulplace to walk, run, or relax amidst theblooms, - please take time to enjoy theculture and charm of this European city.

In addition to the sights and glories of

this historical city, I know you will enjoythe outstanding scientific program thathas been developed by the ProgramCommittee, under the direction ofChairpersons Niv Ad, MD, Bob Kiaii, MDFranca M.A. Melfi, MD., Daniel L. Miller,MD. The ISMICS Annual Meeting hasalways been the forum for presenting thelatest innovations in our field and thisyear’s meeting will present and reviewnew technologies, techniques, and ideasthat are changing our specialty. There arecomprehensive sessions in both cardio-vascular and thoracic surgery.

The program begins on Wednesdaywith a full day Masters Day Program. Themorning courses will feature concurrentsessions including RoboticRevascularization, Off Pump Surgery andAtrial Fibrillation. The afternoon willfeature Minimally Invasive Valve Surgery,Transcatheter Valves and ThoracicRobotic Surgery. The format has beenmodified to encourage more interaction

Prague, known as the City of a Thousand Spires, has become one ofEurope’s favorite travel destinations and welcomes visitors to a citythat is both historical and cosmopolitan. There are plenty of castlesand churches to visit, as well as modern museums, restaurants, andgalleries.

“The Future ofCardiothoracic Care:Policy, Politics and

Performance”

MAQUET Cardiovascular LLC

45 Barbour Pond Drive

Wayne, NJ 07470

Phone: +1 (408) 635-6800

Phone Toll Free: +1 (888) 880-2874

Fax: +1 (408) 635-0717

Fax Toll Free: +1 (888) 899-2874

CardiacSurgery@maquet.com

www.maquet.com

Visit us at booth #17 for further details about our lunch symposium.

When: Friday, June 14th Time: 12:20 pmRoom: Athens & Barcelona & Berlin & Brussels

We look forward to meeting you!

MCV00011477 Rev B

THREE THORACOTOMY BLADE SIZES BLADES TILT UP TO 30° TWO IMA BLADE SIZESBLADES TILT UP TO 30°

MIRA-i CS Retractor has a unique Pivot Mechanism that allows blades to tilt up to 30° –

maximizing access, instrument maneuverability and visibility without increasing the incision length.

MAQUET Introduces an Innovative Retractor System, for Minimally Invasive CABG Procedures.

maximizing access, instrument maneuverability and visibility without increasing the incision length.

TWO IMA BLADE SIZES

® MAQUET Registered Trademark of MAQUET GmbH & Co. KG • Copyright MAQUET Cardiovascular LLC or its affiliates. All rights reserved.

CAUTION: Federal (U.S.A.) law restricts this device to sale, distribution and use by or on the order of a physician.

MIRA-i_ISMICS_Daily.indd 1 5/21/13 11:15 AM

ISMICS INSIDER12-15 JUNE

3www.ismics.org

MAQUET EDITORIAL: Hybrid Coronary Revascularization: Superior Alternative in Left Main Disease?Michael E. Halkos, MD, Henry A. Liberman, MD and John D. Puskas, MD

Emory University, Atlanta, GA

Coronary artery bypass grafting (CABG) has been regarded as the treatment choice forunprotected left main (LM) coronary artery disease. However, recent clinical guidelines haveupgraded PCI to a viable alternative in selected LM patients.1,2 PCI offers tangible short-termadvantages over CABG as it is less invasive, reduces hospitalization duration and avoids thedisability of surgical recovery.

Hybrid coronary revascularization (HCR) may represent a valuable alternative to bothtraditional CABG and unprotected LM stenting. Combining the durability and survival advan-tage of the LIMA-LAD graft with less-invasive PCI using drug-eluting stents (DES) to treatnon-LAD vessels may reduce some of the morbidity associated with CABG and reduce theincidence of repeat revascularization associated with an all-percutaneous strategy.

HCR was introduced at Emory University in 2003. Since that time, it has come to com-

prise 20% revascularization procedures for patients with multivessel disease. Since 2009,LIMA harvesting has been performed with robotic assistance. The anastomosis is performedmanually via a 3-4cm non-rib-spreading anterolateral thoracotomy incision under direct vi-sion without cardiopulmonary bypass.

All HCR patients had a minimally invasive LIMA-LAD bypass performed before or con-comitant with PCI. The majority of lesions involved the distal LM (15/27). The majority of PCIprocedures were performed with DES (92.6%). With the exception of 1 patient, the LM wasstented into the circumflex coronary artery. The average SYNTAX score of HCR patients was23.1.

In-hospital outcomes, were similar between treatment groups, with the exception of theneed for blood transfusion, which was reduced with HCR (p = 0.01). Two patients in the HCRgroup required repeat PCI (1 in-stent restenosis, 1 progression of native disease), and 1OPCAB patient who required repeat PCI (saphenous vein graft) at a median follow up of 3.2years. No patients required reoperation.

Since this publication, HCR has been performed in an additional 20 patients with excel-lent results. The most suitable anatomy for left main hybrid approaches are patients witheither distal left main lesions extending into the bifurcation or any left main lesion plus proxi-mal LAD disease in addition to other lesions. This eliminates concerns for competitive flowbetween a percutaneously treated left main lesion and the LIMA-LAD graft.

In summary, HCR represents a safe and effective strategy with equivalent in-hospitaloutcomes for carefully selected patients with LM coronary disease. Further long-term studieswill help identify the optimal patient population in which this novel approach can be applied.References:1. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the EuropeanAssociation for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interven-tions (EAPCI), Guidelines on myocardial revascularization. Eur Heart J. 2010 Oct;31(20):2501-55.2. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary. Circulation. 2011 Dec6;124(23):2610-42.3. Halkos ME et al.Hybrid coronary revascularization versus off-pump coronary artery bypass for the treatment of leftmain coronary stenosis. Ann Thorac Surg. 2011 Dec;92(6):2155-60.

Technical Challenges: Pitfalls and DisastersWednesday, 19.00 – 21.00

Chair: Valavanur A. Subramanian, MD,St. Lukes-Roosevelt Hospital & Beth Israel Medical Center, New York, New YorkCo-Chair: Alex Zapolanski, MD, The Valley Hospital, Ridgewood, New Jersey

Recurrent Echinococcal Cyst: Expect UnexpectedDavid Zeltsman, MD New York, NY, USA

Bronchial Obstruction following VATS Lobectomy: Diagnosis And TherapeuticChallenge

In Kyu Park, MD Seoul, Republic of KoreaHemodynamic Collapse during TAVI - Successful Rescue

Daniel Watson, MD Columbus, Ohio,USAMajor Rhromboembolic Complication in Transfemoral TAVI Procedure -Clinicopathological Correlate

Vivek Srivastava, MD Blackpool, United KingdomSerial Complications after Repair 0f Type A Aortic Dissection

Michal Nozdrzykowski, MD Leipzig,GermanyHemolysis After Total Arch Replacement with the Frozen Elephant Trunk

Yoshitsugu Nakamura, MD Hidaka, JapanRupture of the Right Coronary Artery after Aortic Root Replacement:What Do I Do Now?

Jonathan Hemli, MD New York, NY, USAValve Embolization during TAVI with Surgical Rescue

Nikolaos Bonaros, MD Innsbruck, AustriaValve-In-Valve-In-Ring Following a Stenotic Mitral Annuloplasty Repair

Gry Dahle, MD, Oslo, NorwayDisaster during Percutaneous Trans Catheter closure of Aortic ParaValvularLeak...Misdiagnosis

Nirav Patel, MD/V.A.Subramanian, MD New York, NY, USAReefing of Aortic Sinuses to Avoid Root Replacement in a Complex Reoperation

Alex Zapolanski, MD New Jersey USA

CO-CHAIRS: Niv Ad, MD, Bob B. Kiaii, MD,Franca M.A. Melfi, MD, Daniel L. Miller, MD

SCIENTIFIC PROGRAM COMMITTEE

Husam H. Balkhy, M.D.Jacob Bergsland, M.D.Gianluigi Bisleri, M.D.

Nikolaos Bonaros, M.D.W. Douglas Boyd, M.D.Nicolas A. Brozzi, M.D.Louis A. Brunsting, M.D.Charles C. Canver, M.D.

Michael Chu, M.D., FRCSGareth Crouch, M.D.

Pero Curcic, M.D.Todd L. Demmy, M.D.Christian Detter, M.D.

Gabriele Di Giammarco, M.D.Mark Dylewski, M.D.Seth D. Force, M.D.

Changqing Gao, M.D.Kristopher M. George, M.D.

Mattia Glauber, M.D.Diego Gonzalez Rivas, M.D.

Jurg Grunenfelder, M.D.Vassilios Gulielmos, M.D.Hitoshi Hirose, M.D., Ph.D

Homayoun Jalali, M.D.Tsuyoshi Kaneko, M.D.

Sandeep J. Khandhar, M.D.Ali Khoynezhad, M.D.

Bob B. Kiaii, M.D.Andy C. Kiser, M.D.

Antonio Laudito, M.D.

Eric J. Lehr, M.D., Ph.DClifton T.P. Lewis, M.D.Pierluca Lombardi, M.D.Lucian Lozonschi, M.D.

Yousuf Mahomed, M.D., FACSRajneesh Malhotra, M.D.

Alexander R. Marmureanu, M.D.Saqib Masroor, M.D., MHS

Joseph T. McGinn, M.D.Franca M.A. Melfi, M.D.Tomislav Mihaljevic, M.D.

Rodrigo Milani, M.D.Daniel L. Miller, M.D.

Christopher R. Morse, M.D.Martin Oberhoffer, M.D.

Nirav C. Patel, M.D.Robinson Poffo, M.D.Goya V. Raikar, M.D.

Harold G. Roberts, Jr., M.D.Jens C. Ruckert, M.D.

Petrucio A. Sarmento, M.D.Carlo Savini, M.D.

Takeo Tedoriya, M.D.Vinod H. Thourani, M.D.

Hendrik Treede, M.D.Alfredo Trento, M.D.Benny Weksler, M.D.

Bryan A. Whitson, M.D., PhDRashmi Yadav, M.D.

Alex Zapolanski, M.D.

ISMICS INSIDER 2O13 ANNUAL MEETING

Hilton Prague, Czech Republic4

A Message From Your ISMICS Executive Director

Aurelie M. Alger, JD

(continued on page 14)

INDUSTRY SPONSORED SYMPOSIA

Thursday, 13 June 2013

11.45-13.15 (11:45am-1:15pm) Palmovka & Rokoska & HerkovkaCan Cardiac Tissue be Regenerated

by CorMatrix ECM?Hosted by CorMatrix

11.45-13.15 (11:45am-1:15pm) Roma & Vienna & MadridThe State of the Art in Beating Heart Surgical Ablation

Hosted by Estech

11.45-13.15 (11:45am-1:15pm) Athens & Barcelona &Berlin & Brussels

MICS in OR: When Technology andSurgeon Experience Make the Difference

Hosted by Sorin Group

These topic-driven sessions provide attendees with current, detailed information on new techniques and technologies. Thefollowing companies are supporting industry symposia, which are not part of the official ISMICS scientific program.

Friday, 14 June 2013

06.30 - 07.50 (6:30am - 7:50am) Palmovka & Rokoska & HerkovkaInitiating MICS Strategies in Your Daily Practice

Hosted by Medtronic

12.20 - 13.50 (12:20pm - 1:50pm) Roma & Vienna & MadridTreatment Of Aortic Stenosis: Tailoring The Best

Combination Of Options For Your PatientsHosted by Edwards Lifesciences

12.20 - 13.50 (12:20pm - 1:50pm) Athens & Barcelona &Berlin & Brussels

A Multi-Pronged Approach Is Required ToReduce CABG Stroke Rates

Hosted by MAQUET

12.20 - 13.50 (12:20pm - 1:50pm) Palmovka & Rokoska & HerkovkaLifetime Management of Valve Disease in the Era of TAVR

Hosted by Medtronic

I wish all ourISMICSmembers andAnnual MeetingAttendees awarm welcometo Prague, oneof Europe’s mostbeautiful capitalcities. We

identified Prague as a venue immediatelyafter our Berlin Meeting in 2010, andwhile it hardly seems that three yearshave passed, here we are gatheredtogether for ISMICS 16th Annual ScientificMeeting.

As I write this message, I am de-lighted to inform you that our pre-registration as of June 6th is 497, with atotal of 447 Professional Pre-Registrants.This is our second highest professionalmedical pre-registration in ISMICShistory, only behind 2005 in New York.Over the past 5 years we have seenISMICS attendance continue to increase,with last year’s Los Angeles meetingsetting our all-time West Coast recordwith 534 professional medical attendees.With a few hundred industry partners alsoparticipating this year, we anticipate totalattendance of over 800 at this year’smeeting.

2012 into 2013 has seen ISMICSmove ahead with implementation of itsStrategic Plan, which called for expansionof scientific programming to include allforms of innovation in surgery, tech-niques, and technological advances.Abstract review criteria was tightened toask reviewers to consider if the contentsubmitted was “ISMICS” in nature – inother words, minimally invasive, orinnovative, or forward-thinking. There istremendous commitment on the part ofyour ISMICS leadership to keep thesociety true to its origins and not have itlose its non-traditional and cutting edgepersonality. This year’s Program Chairson the Cardiac Side, Drs. Niv Ad and BobKiaii, split the Program Committee intotwo distinct onsite review groups so thatmore in-depth analysis of papers could bemade. And our Thoracic Chairs, Drs.Daniel Miller and Franca Melfi, reviewedthe thoracic papers to ensure that theytoo remained at the forefront of what isrelevant in innovative and minimallyinvasive thoracic surgery. I am sure youwill find the content in both the cardiacand thoracic sessions to be both highquality and very informative.

Also in an effort to keep things fresh,the format of our Masters Day waschanged – and this year both the morning

and afternoon sessions start off in asingle room with one portion focused onprogramming of interest to all three topic-driven sessions, presented through Stateof the Art Lectures and then “GreatDebates.” Then the sessions split foranother two hours of topic-specificprogramming. And on Wednesdayafternoon ISMICS also welcomes apartner in educational programming in thefirst-ever offering of a joint ISMICS/EACTS course on Thoracic RoboticSurgery. Friday morning at ISMICS willfeature a “Live on Tape” session withthree Live in a Box videos being pre-sented on Transapical Valves, Mini-MitralValves, and Ablation. And finally,Saturday morning ushers in two morenew program concepts, shortenedpresentations and mini-cardiac debates,as well as a Thoracic “Movie Day.” Wehope that you can attend these newsessions, and look forward to yourfeedback post-meeting.

Our featured Lectures this yearcelebrate two of ISMICS’ own, Dr. JosephBavaria offering the Keynote Lecture of“Integrating Innovation by ChangingCulture,” and Dr. Willian “Billy” Cohngiving the Kit V. Arom Lecture which willbe entitled “Medical Device Innovation101: One Surgeon’s Perspective on

Developing Disruptive Technology.”For the 2013 Expert Panel Consensus

Conference, ISMICS took the 10th

anniversary of that program back to itsroots with a revisit of off-pump surgery.Consensus Panel Chair Dr. John Puskaswill present the preliminary report of theExpert Panel, supplemented by apresentation on the Research by Dr. DavyCheng and Janet Martin, PhD.

ISMICS continues to work with ourindustry partners in these challengingeconomic times, and the society remainsvery grateful for their continued commit-

There is tremendouscommitment on thepart of your ISMICSleadership to keep

the society true to itsorigins and not haveit lose its non-tradi-

tional and cuttingedge personality.

www.estech.com

Unique suction application eliminates heat sink effect.

When we set out to design the new COBRA Fusion, our goal was to create a new standard of

performance for the treatment of Atrial Fibrillation. The result is a uniquely adaptable and

effective platform that you have to experience to believe.

The first and only device with proprietary VersapolarTM technology, COBRA Fusion can deliver

both Bipolar and Monopolar energy. Powered by patented TCRF (Temperature Controlled

Radiofrequency), Fusion incorporates a unique suction design that eliminates the heat sink

effect, enabling surgeons to create reproducible transmural lesions and return patients to

normal sinus rhythm.

Designed to deliver better outcomes – that’s the power of Fusion.

Visit us at Booth #7

Estech COBRA Fusion® Ablation System

DESIGNED TO

PERFORMBUILT TO

AMAZE

The Estech COBRA Fusion is intended to ablate cardiac tissue during cardiac surgery using radiofrequency (RF) energy when connected directly to the Estech Electrosurgical Unit (ESU). The Estech COBRA Fusion may be used for temporary cardiac pacing, sensing, recording, and stimulation during the evaluation of cardiac arrhythmias during surgery when connected to a temporary external cardiac pacemaker or recording device. Estech does not promote off-label use of its products and their use is at the discretion of the cardiac surgeon. Estech is undertaking an IDE clinical trial and subsequent PMA submission to obtain a specific atrial fibrillation indication. In Europe, the Estech COBRA RF ablation products are CE marked with an indication for the treatment of atrial fibrillation by ablating cardiac tissue during surgery. Refer to the Instructions for Use (IFU) for detailed information on device description, instructions, contraindications, warnings and precautions.

UC201400493 EE© Medtronic, Inc. 2013. All Rights Reserved

OpportunityFind

in Change

Visit us at Booth 21, and at Sim City where you can test your skills through hands-on simulation.

Cardiopulmonary Bypass Simulation: Perform hands-on aortic cannulation with the � rst fully-interactive cardiac perfusion simulator.

Beating Heart, Minimally Invasive Simulator: See the access you can achieve through a small thoracotomy, and test your MICS CABG sewing skills on a beating heart.

Change is nothing new to cardiac surgery.

And with change comes opportunity.

As the global leader in medical technology

for over 60 years, Medtronic o� ers solutions

that create a world of possibility…simple,

clear options that help you decide what’s best.

Visit us at Booth 21, and at Sim City where you

As the global leader in medical technology

for over 60 years, Medtronic o� ers solutions

that create a world of possibility…simple,

clear options that help you decide what’s best.

Visit us at Booth 21, and at Sim City where you can test your skills through hands-on simulation.

Cardiopulmonary Bypass Simulation:with the � rst fully-interactive cardiac perfusion simulator.

Beating Heart, Minimally Invasive Simulator:achieve through a small thoracotomy, and test your MICS CABG sewing skills on a beating heart.

Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you

As the global leader in medical technology

for over 60 years, Medtronic o� ers solutions

that create a world of possibility…simple,

clear options that help you decide what’s best.

Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you can test your skills through hands-on simulation.

Cardiopulmonary Bypass Simulation:with the � rst fully-interactive cardiac perfusion simulator.

Beating Heart, Minimally Invasive Simulator:achieve through a small thoracotomy, and test your MICS CABG sewing skills on a beating heart.

Visit us at Booth 21, and at Sim City where you can test your skills through hands-on simulation.

Cardiopulmonary Bypass Simulation:with the � rst fully-interactive cardiac perfusion simulator.

Beating Heart, Minimally Invasive Simulator:achieve through a small thoracotomy, and test your MICS CABG sewing skills on a beating heart.

Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you Visit us at Booth 21, and at Sim City where you

201400493_EE.indd 1 5/22/13 1:26 PM

ISMICS INSIDER12-15 JUNE

7www.ismics.org

ISMICS 2013 Consensus Statement:OPCAB/Off Pump Surgery

ISMICS CONSENSUS STATEMENTS

2012 TAVI2011 Blood Management in

Cardiothoracic Surgery2010 Mini-Mitral Valve Repair or

Replacement (MVR) vs.Conventional MVR: A Sys-tematic Review & Meta-Analysis of Controlled Trials

2009 Atrial Fibrillation2008 Stentless versus Stented

Aortic Valves2007 Video-Assisted

ThoracicSurgery in LungCancer Resection: IsVATS Lobectomy AdvancingPatient Care

2006 TransmyocardialRevascularization

2005 Endoscopic VascularHarvesting

2004 Off-Pump Surgery

Don’t Miss thePanel’s Report

Friday, 1 June / 10.00 - 10.40Chair: John Puskas, MD

Researcher: Davy Cheng, MDStatistician: Janet Martin, PhD

OPCAB Consensus Panel

John Puskas, MD, CHAIR, USAStefano Benussi, MD, Italy

Johannes Bonatti, MD, UAEDavy Cheng, MD, Canada

Anno Diegeler, MD, GermanyFrancis Ferdinand, MD, USATeresa Kieser, MD, Canada

Michael Mack, MD, USAJanet Martin, PhD, Ontario

Nirav Patel, MD, USAMark Ruel, MPH, CanadaJoseph Sabik, MD, USAVipin Zamvar, FRSC, UK

TheInternationalSociety forMinimallyInvasiveCardiothoracicSurgery(ISMICS) isproud to haveconducted itstenth Expert

Panel Consensus Conference in 2013.This year’s panel, chaired by Dr. John

Puskas of Emory University, focused on“OPCAB/Off-Pump Surgery.” Dr. DavyCheng of London Health Sciences Centrein Ontario, Canada served as primaryresearcher and biostatician. The Consen-sus Conference was held last month atThe Shelbourne Dublin Hotel in Dublin,Ireland on 25-27 May 2013.

ISMICS has assembled this interna-tional panel of experts to share theirknowledge and expertise and to reviewthe current literature as related to OffPump Coronary Artery Bypass Surgery.

The main objective of the conference wasto determine whether off-pump coronaryartery bypass surgery (OPCAB) issuperior to conventional on-pumpcoronary artery bypass surgery (CCAB)with respect to clinical outcomes andresource-related outcomes, and todetermine whether effects differ acrosspre-specified risk groups and settings.

The primary outcomes of interest aredeath, stroke, AMI, RBC tx and need forreintervention, both in the short term andlong-term follow-up. Secondary outcomesinvolve all other clinically relevantoutcomes listed above, and resource-related outcomes.Systematic review ofrandomized trials were conductedaccording to recent guidelines set out byCochrane Collaboration, and will bereported according to the PRISMAguidelines. Comprehensive searches ofthe literature were done in Medline,Embase, and Cochrane library.

More on the statement will beprovided in the second Prague meetingissue of the ISMICSInsider.

ISMICS INSIDER 2O13 ANNUAL MEETING

Hilton Prague, Czech Republic8

2O13 ISMICS EXHIBITORSThe Exhibition Hall is located in Congress Hall.

Wednesday 30 May 17.00 – 19.00 (Welcome Reception at 17.00)

Thursday 31 May 07.30 – 11.30 &13.30 – 18.00 (Exhibit Hall Reception at 17.00)

Friday 1 June 07.00 – 10.30 & 13.30 – 17.15

ATRICURE, INC. 256217 Center Park Drive

West Chester, Ohio 45069 USAAtriCure, the leader in cardiac surgical ablationof Afib featuring bipolar RF clamps, pens andcryothermic energy devices. Providing CV Sur-geons with the only FDA endorsed surgical Afibcertification course. AtriCure’s portfolio includesthe AtriClip®, which is the only atraumatic de-vice FDA cleared specifically designed for LAAexclusion.

www.atricure.com

B. BRAUN AESCULAP 32Am Aesculap-Platz,

78532 Tüttlingen, GermanySurgery and Aesculap - a close relationship forover 140 years. With useful products and pro-cess-oriented advice we are pursuing a goal: toimprove therapies and make processes moreefficient. Whether with surgical instruments, su-ture materials, implants, or sterile containers, westrive for innovations which result in medicaladvances. Aesculap – a B. Braun company.

www.bbraun.com,www.aesculap.de

BARD DAVOL 15Forest House, Tailgate Forest, Business Park,

Brighton Rd., Crawley, West Sussex,RH119BP, UK

ProGel®PLATINUM: pleural air leak sealant is anew recombinant hydrogel specifically designedfor cardio-thoracic surgeons. ProGel, the onlyFDA approved product for pleural air leaks is asingle use device for application on the visceralpleura following standard visceral pleural closuretechniques. Formed as a result of mixing 2 com-ponents: Upon mixing, a clear flexible hydrogelis formed, and can be sprayed on the lungparenchym.

www.davol.com

BIOVENTRIX 4812647 Alocosta Boulevard

San Ramon, CA 94583, USABioVentrix is a privately held medical device com-pany that is based in San Ramon, USA. Wedesign and manufacture minimally-invasive de-vices for the treatment of congestive heart fail-ure. The Revivent™ Myocardial Anchoring Sys-tem, our first generation device, helps restorethe shape and size of the left ventricle in post-MIpatients with LV antero-septal scar. The LeftVentricular Restoration (LVR) is achieved througha novel procedure known as Less Invasive Ven-tricular Enhancement (LIVE™).

CORMATRIXCARDIOVASCULAR, INC. 5

286 South Main Street, Suite 200,Alpharetta, GA, 30009, USA

CorMatrix® Cardiovascular markets its ECM®Technology biomaterial devices for pericardialclosure, cardiac tissue repair, and carotid repairand is currently conducting preclinical studies toevaluate future applications in heart failure aswell as other cardiovascular applications.

www.cormatrix.com

ISMICS INSIDER12-15 JUNE

9www.ismics.org

ISMICS is pleased to be able to

provide an opportunity for

surgeons to view and test drive

the newest products, devices,

and technologies available.

DENDRITE CLINICALSYSTEMS, LTD. 46

The Hub, Station Road, Henley-on-Thames,Oxfordshire RG9 1AY UK

Dendrite is a specialist supplier of cardiac sur-gery database software, with installations in spe-cialist cardiac centres in over 40 countries andfor 10 national and international cardiac surgeryregistries including Euromacs and for the Ac-quired Cardiac Surgery Registry for EACTS.Visit our exhibition booth for a demonstration ofour software, now available for the iPad and inmulti-lingual formats.

www.e-dendrite.com

EACTS 47Eacts House, Madeiza Walk,8LU 1EU Windsor, Berks, UK

The EACTS is the largest European Associationdevoted to the practice of Cardio-thoracic sur-gery. The main objects of the Association are toadvance education in the field of cardio-thoracicsurgery and to promote, for the public benefit,research into cardiovascular and thoracic physi-ology and therapy and to correlate and dissemi-nate the useful results thereof. Visit the boothfor information on membership, future meetings,EACTS Academy and all other activities ofEACTS. www.eacts.org

EDWARDS LIFESCIENCES 23Rue de l’Etraz 70, 1260 Nyon, Switzerland

Edwards Lifesciences is the global leader in thescience of heart valves and hemodynamic moni-toring. Driven by a passion to help patients, thecompany partners with clinicians to develop in-novative technologies in the areas of structuralheart disease and critical care monitoring thatenable them to save and enhance lives.

www.edwards.com/eu

ESTECH 72603 Camino Ramon, Suite 100

San Ramon, CA 94503, USAEstech develops and markets a broad portfolioof innovative medical devices and disposablesthat enable cardiac surgeons worldwide to per-form a variety of traditional and minimally inva-sive surgical procedures.

www.estech.com

FEHLING INSTRUMENTS GMBH& CO. KG 4

Hanauer Landstr. 7A,63791 Karlstein, Germany

FEHLING INSTRUMENTS is a traditional familyowned and family run company with more thanthirty years of experience in the medical busi-ness. FEHLING INSTRUMENTS develops,manufactures, and distributes surgical instru-ments, implants and single use products for usemainly in the OR and provides all correspondingrepair service. FEHLING INSTRUMENTS is con-stantly striving for excellence in function andeconomy of products. This objective is achievedby continuous innovation in materials, mechan-ics and design.

www.fehling-instruments.de

GEISTER MEDIZINTECHNIK 40Fohrenstrasse 2, D-78532

Tüttlingen, GermanyIn close collaboration with partners from clinicalresearch and the medical industry, our aim is tomake a contribution with technical innovationsfor minimally invasive surgical procedures incardiovascular surgery. Our experienced instru-ment masters in Tuttlingen are dedicated tomanufacturing one of the best and highest qual-ity surgical instruments available worldwide.For more information: www.geister.com Thebetter way to operate™

www.geister.com

GENESEE BIOMEDICAL, INC. 31308 S. Jason Street

Denver, CO 80223, USADesign Beyond Standard. Genesee BioMedical,Inc. provides unique devices for cardiothoracicsurgery including sternal/thoracic valve retrac-tors, instruments for MICS, coronary graft mark-ers, suture guards, retraction clips and myocar-dial needles. All products are CE approved.info@geneseebiomedical.com.

www.geneseebiomedical.com

INTUITIVE SURGICAL, INC. 11266 Kifer Rd, Bldg 101,

Sunnyvale, CA 94086, USAIntuitive Surgical is the global leader in minimallyinvasive, robotic-assisted surgery. Its da Vinci®System – with a 3D-HD vision system andEndoWrist® instrumentation – enables surgeonsto offer a minimally invasive approach to manypatients. With da Vinci, cardiothoracic surgerypatients avoid the large incision and rib-spread-ing associated with open surgery.

www.intuitivesurgical.com

JENAVALVE 35Guerickestrabe 25, 80805 Munich, Germany

JenaValveTM Technology is an innovativ medicaldevice company focused on developingtranscatheter valve implantation systems to treatpatients suffering from aortic valve disease. Thecompany develops both transapical andtransfemoral TAVI systems to address the needsof the cardiac surgeon and cardiologist, respec-tively. The company’s products are currently tar-geted at high-risk patients unsuitable for openheart surgery. JenaValve Technology’s head-quarters are in Munich, Germany. Additional com-pany information is available atwww.jenavalve.com

www.jenavalve.de

KARL STORZ GMBH & Co. KG 6

Mittelstr. 8, 78532 Tüttlingen, GermanyKARL STORZ is a renowned manufacturer thatis well established in all fields of endoscopy. Thestill family held company has grown to one witha worldwide presence and 5800 employees.KARL STORZ offers a range of both rigid andflexible endoscopes for a broad variety of appli-cations.

www.karlstorz.com

KLS MARTIN GROUP 26Ludwigstaler Straße 132 ,

78532 Tuttlingen, GermanySurgical innovation is the KLS Martin Groupsdriving force since 90 years. Our innovations inall kind of surgical fields simplify the daily rou-tine of surgeons all over the world. The latestinstrument series marCore® is a prime examplemelting the surgeons hand with his tools for mini-mal invasive surgery.

www.klsmartin.com

LSI SOLUTIONS 117796 Victor-Mendon Road,

Victor, NY, 14564, USACOR-KNOT® delivers instant security with au-tomated knotting and integrated suture trimmingin one easy step. COR-KNOT® may reducecardiopulmonary bypass and cross-clamp timein your OR. Visit LSI SOLUTIONS® at booth11 and see the newest edition to the COR-KNOT® family, the CK® Standard.

www.lsisolutions.com

MAQUET MEDICAL SYSTEMS,USA 17

45 Barbour Pond Road Wayne, NJ 07470, USA

MIRA-i CS Retractor - A modular system fea-turing a unique, Pivoting Mechanism to maxi-mize access and visibility through the smallestof incisions.HEARTSTRING III PROXIMAL SEAL SYSTEMAllows you to achieve clampless hemostasisduring CABG proximal anastomoses while su-turing with your own hand.ACROBAT-i - Is an innovative mechanical tis-sue stabilization device.VASOVIEW HEMOPRO 2 - This EVH devicevirtually eliminates thermal spread and helpsharvesters safely acquire high-quality conduitsfor coronary artery bypass graft surgery.TIGERPAW® SYSTEM II - Achieve 100% leftatrial appendage occlusion. This device featuresan exceptionally soft silicone Fastener that con-forms to the patient’s appendage anatomy andtissue thickness.

www.maquet.com

MEDISTIM 27PB 6471 Etterstad NO-0605 Oslo, Norway

Medistim is the innovator and market leaderwithin intra-operative transit time flow measure-ment (TTFM) and ultrasound imaging. We de-velop, manufacture and bring to market the qual-ity assessment systems VeriQ and VeriQ C forcardiac, vascular and transplant surgery. OurTTFM technology became part of the ESC/EACTS guidelines on myocardialrevascularization in 2010, and in 2011 our VeriQTTFM system was recommended by the Na-tional Institute for Health and Clinical Excellence(NICE) for routine use within the UK nationalhealth system (NHS) based on clinical as wellas economic benefits.

www.medistim.com

MEDTRONIC, INC. 21710 Medtronic Parkway NE,

Minneapolis, Minnesota 55432 USAFind opportunity in change and considerMedtronic’s intuitive solutions in structural heartdisease, including tissue, mechanical andtranscatheter valves; irrigated RF and cryo sur-gical ablation devices; OPCAB, MICS CABG,cannulae, and perfusion products.

www.medtronic.com

SCANLAN INTERNATIONAL, INC. 29

One Scanlan Plaza,St. Paul, MN 55107, USAHighest quality surgical products designed andmanufactured by the Scanlan family since 1921.Over 3,000 titanium and stainless steel precisioninstruments including: VATS / MIS thoracoscopicinstruments, SCANLAN® Caliper and MEMORYinstruments, SCANLAN® LEGACY titaniumneedle holders and forceps. Single-use productsinclude SCANLAN® Aorta/Vein Punch, VASCU-STATT® bulldog clamps and graft markers.

www.scanlaninternational.com

SMARTCANULA LLC 4921 Ave. Du Tribunal Federal, CH-1105

Lausanne, SwitzerlandSmartcanula LLC is the leading manufacturer foradvanced interfaces between the circulatory sys-tem and cardio-pulmonary bypass, the key tech-nology for cardiac surgery. The innovative smartcannulation principle, which is based on collapsedcannula insertion and expansion within the tar-get vessels, allows for un-matched venous drain-age. A new special MICS smartcanula(R) will bepresented. www.smartcanula.com

SORIN GROUP 914401 W. 65th Way,Arvada, CO 80004, USA

SORIN Group (www.sorin.com ) is a global, medi-cal device company and a leader in the treatmentof cardiovascular diseases. The Company devel-ops, manufactures, and markets medical tech-nologies for cardiac surgery and for the treat-ment of cardiac rhythm disorders. Sorin Groupoffers a complete range of products and acces-sories for minimally invasive incisions cardiacsurgery: visit us at booth # 9 to see and touch thelatest product portfolio for cannulae, surgical in-struments, Perceval S suturless heart valve andMemo 3D annuloplasty ring.Contacts: info.cardiacsurgery@sorin.com

www.sorin.com

ST. JUDE MEDICAL 45SJM Coordination Center BVBA, Da Vinci laan

11 - Box F1,B-1935 Zaventem, BelgiumSt. Jude Medical develops medical technologydesigned to put more control into the hands ofthose who treat cardiac, neurological and chronicpain patients worldwide. The company is dedi-cated to advancing the practice of medicine byreducing risk wherever possible and contribut-ing to successful patient outcomes. Learn moreat www.sjmprofessional.com

WEXLER SURGICAL 3411333 Chimney Rock Road, Suite #110,

Houston, Texas 77035, USAWexler Surgical designs and manufactures tita-nium and stainless steel specialty surgical instru-ments and products for Cardiovascular, Thoracic,and Micro Surgery. Visit us at

www.wexlersurgical.com

ISMICS INSIDER 2O13 ANNUAL MEETING

Hilton Prague, Czech Republic10

8.00 – 10.00 MORNING GENERAL SESSION

State of the Art Lecture: Robotic RevascularizationJohannes Bonatti, MD

State of the Art Lecture: CABGDavid Taggart, MD

State of the Art Lecture: Surgical Ablation Atrial FibrillationNiv Ad, MD

Great Debate: Atrial Fibrillation Monitoring and Follow-UpRalph Damiano, MD and Thorsten Hanke, MD

Great Debate: OPCAB is Superior to ONCAB for Most PatientsJohn Puskas, MD and Michael Halkos, MD

10.00 – 12.15 MORNING FOCUSED SESSIONS

ROBOTIC REVASCULARIZATION Chair: Husam Balkhy, MDSternal Sparing Coronary Revascularization: Why We Need the RobotHow Does the Established Surgeon Get Started?Robotic Revasc in Europe: Where Do We Go From Here?What is the Best Way to Achieve a Robotic Revascularization/Hybrid

Database?Robotic Revascularization: Cannulation TechniquesRobotic Revasc Experience in AsiaConnector TECABHybrid Coronary Revascularization Cardiologist’s ViewHybrid Coronary Revascularization Surgeon’s ViewImaging for Robotic Revascularization: Pre and Intra-op Considerations

OFF PUMP SURGERY Chair: John Puskas, MDRobotic CABGHybrid CABGeMeshAnastomotic ConnectorsOPCAB Techniques

ATRIAL FIBRILLATION Chairs: Piotr Suwalski, MD and Niv Ad, MDAn OverviewTotally Thoracoscopic Bilateral Ablation with Left Atrial Appendage ExclusionRobotic ApproachHow Should the Left Atrial Appendage be Managed Minimally InvasivelyWhat is the Ideal Hybrid Approach – An EPThe Industry Corner

13.00 – 17.15 AFTERNOON GENERAL SESSION

State of the Art Lecture: Planning and Assessing thePerfect Mitral Valve Repair W. Randolph Chitwood, Jr., MD

State of the Art Lecture: Transcatheter ValvesGregory Fontana, MD

State of the Art Lecture: Background and CurrentLimitations of Surgical Robotics

Great Debate: Mitral Valves: Transcatheter Mitral ValveRepair Will Become Standard of Care

Pro: Hermann Reichenspurner, MD / Con: Volkmar Falk, MDGreat Debate: Is Time for Expanding TAVI Indications to

Medium Risk Patients?

15:00 - 17:15 AFTERNOON FOCUSED SESSIONS

MINIMALLY INVASIVE VALVE SURGERY Chair: W. Randolph Chitwood, Jr., MDSimplifying Mitral Valve RepairVideoscopic Mitral Valve Repair: How I Do It!Robotic Mitral Valve Repair: How I Do It!Avoid Complications in Minimally Invasive Mitral Surgery

TRANSCATHETER VALVES Chair: Gino Gerosa, MDTAVI Devices: An Updated OverviewTAVI Crucial Steps: Patient Selection, Access and SizingTAVI Crucial Steps: Implantation and Management of ComplicationsIs There a True “No Access” TAVI Patient?Quality of Life and Cost-Effectiveness: Two Issues That Should

Not Be UnderestimatedAn Emerging Alternative: Transaortic TAVIValve-in-Valve Heart Valve ImplantationTransapical Closure Devices

JOINT ISMICS/EACTS COURSE: THORACIC ROBOTIC SURGERY

Chair: Franca Melfi, MD

THORACIC SURGERY Chair: Kemp H. Kernstine, MD, PhDLearning Curve in Thoracic Robot SurgeryRobotic Versus Open Thoracic Surgery – Feasibility versus ValidityCurrent Results of Robotic Thoracic SurgeryStrategies for Challenging in Robotic Thoracic Surgery

ROBOTIC CARDIAC SURGERY Chair: Johannes Bonatti, MDPrinciples of Robotic Cardiac SurgeryRobotic Mitral Valve Repair – Endoballon MethodRobotic Mitral Valve Repair – Chitwood Clamp MethodRobotic Coronary SurgeryChallenges in Robotic Cardiac Revascularization

ISMICS Masters Day Program - Wednesday

ISMICS Members’Business Meeting

· Browse the list of all sessions and speakers;· View the entire schedule of Annual Meeting

activities;· Search for information regarding the Annual

Meeting program, abstracts, speakers andexhibitors;

· Create your own personal schedule inside thenative app;

· Take notes on any session in the native app;· And more....

Download the ISMICS Meeting APP to your Mobile Device

All ISMICSmembers arerequested toattend theMembers’BusinessMeeting, scheduled for Saturdaymorning, 09.00-09.30 and held in theScientific Session Hall in CongressHall 2-3.

ISMICS INSIDER12-15 JUNE

11www.ismics.org

POSTER COMPETITION GOES ELECTRONICThe ISMICS Poster Competition remains one of the highlights of the Annual Meeting and provides attendees a

unique opportunity to review their colleagues’ research. The Poster Competition is a peer-reviewed session conductedin two rounds. The First Round will be delivered on Thursday from 17.00 - 18.00 in the Congress Hall, with topic groupspresenting concurrently. Over 100 posters will be presented. For the first time, all ISMICS competition and displayposters will be persented in an all-electronic format.

Topics include: Revascularization Robotic, Heart Failure Revascularization, Imaging And Facilitating, Technology ForCardiac Surgery, Valve Aortic, Valve New Designs, Valve Mitral Mini, Thoracic, Aortic And Endovascular Therapies,Arrhythmias, and Perfusion. During these rapid-fire presentations, authors are allowed a maximum of three minutes,with two minutes for discussion. Participants score each presentation on quality of the presentation and significance ofthe research. Semi-finalists are selected for the final round and will be announced on Friday morning.

Final Rounds will be delivered from thepodium in the main scientific session onFriday from 16.30 - 17.30. Presenters areagain allowed a maximum of three minutes,followed by two minutes for audiencequestions and discussion. Judges willreview and the winner will be announced onFriday evening.

Good luck to all of the ISMICS posterpresenters.

Chief Moderator: Rex Stanbridge, MDThe first round of the poster competition in Los Angeles, 2012.

Previous Winners

Sreekumar Subramanian 2012

Pencilla Lang 2011

Andrew B. Goldstone 2010

Faraz Kerendi 2009

Tine Philipsen 2008

John D. Puskas 2007

Simon C. Moten 2006

Nimesh Desai 2005

Johannes Bonatti 2003

Vassilios Gulielmos 2002

Fraser D. Rubens 2001

Marc Ruel 2001

ISMICS INSIDER 2O13 ANNUAL MEETING

Hilton Prague, Czech Republic14

2012-2013 Board of Directors

PresidentAlan H. Menkis, MD

Past PresidentJohn L. Knight, MD, FRACS

President-ElectFrancis D. Ferdinand, MD

Vice PresidentVolkmar Falk, MD

SecretaryPaul F. Grundeman, MD, PhD

TreasurerGregory P. Fontana, MD

DirectorsNiv Ad, MDKeith B. Allen, MDTohru Asai, MD, PhDJohannes Bonatti, MDAnson Cheung, MDBob B. Kiaii, MDYoung Tae Kim, MD, PhDFrancesco Maisano, MDDaniel L. Miller, MDSimon C. Moten, MDFranca M.A. Melfi, MDPia S.U. Myken, MD, PhDPiotr Suwalski, MD, PhD

Editor, INNOVATIONSRalph J. Damiano, Jr., MD

Managing Editor, INNOVATIONSCarol Blasberg

ISMICS InsiderThe official newspaper of the ISMICS

2013 Annual MeetingExecutive Director

Aurelie J. Alger, JDAdministrative Director

Elizabeth ChouinardIndustry Relations

Stan AlgerYvonne Grunebaum

Meeting DirectorE.J. Weldon

Meeting ManagerJillian West

Meeting CoordinatorAmanda Carignan

Managing Editor, ISMICS InsiderLorraine M. O’Grady

© Copyright 2013 International Society forMinimally Invasive Cardiothoracic Surgery,500 Cummings Center, Suite 4550, Beverly,Massachusetts 01915, USA.

Produced and distributed by ISMICS. All rightsreserved. No part of this publication may bereproduced or transmitted in any form, by anymeans, without written permission from ISMICS.The opinions expressed in this publication arethose of the presenters and authors and do notnecessarily reflect the views of the Society.

between faculty and attendees, withincreased time for discussion. Wednes-day evening will feature the alwayspopular “Technical Challenges: Pitfallsand Disasters” course, chaired byValavanur A. Subramanian, MD and AlexZapolanski, MD.

New this year will be a special area inthe Exhibit Hall reserved for “hands on”simulation and training - “Sim City” -where you will be able to actually test andpractice various techniques, technologies,and equipment. We encourage you tostop by and experiment.

Speaker highlights include the KitArom lecture by Dr William E. “Billy“Cohn, one of our leading innovators; Dr.Joseph E. Bavaria, a world leader inComplex Aortic Surgery; and Dr. John D.

Welcome from the President (continued from page one)

Puskas, chair of this year’s ConsensusStatement, who will report on OPCAB.

The Social Program takes advantageof our location this year and embracesthe history and architecture of the CzechRepublic. The Attendee Reception at thehistoric Zofin Palace on Friday, capturesthe ambience of Old Europe with amodern edge – entertainment by Rekord!,the rock band led by ISMICS ownrecording artists Volkmar Falk, PiotrSuwalski and colleagues.

I also invite you to join me for thePresident’s Nightcap on Thursdayevening in the Cloud 9 Sky Bar & Lounge.

We look forward to a great meetingand are pleased that you have joined usin Prague. Dìkuji.

From the Executive Director (continued from page 4)

New this year will bea special area in theExhibit Hall reservedfor “hands on” simu-lation and training -“Sim City” - whereyou will be able to

actually test andpractice various tech-

niques, technologies,and equipment.

ment to ISMICS. This year ISMICS hasdebuted a new segment of our hallentitled “Sim City,” which we encourageyou to visit to experience hands-onsimulation opportunities throughout theday. And one tradition ISMICS continuesis the Welcome Reception and Thursdayevening reception held right in the ExhibitHall, so that everyone can spend timemeeting with our industry partners. A listof our supporters and their location in theExhibit Hall and Sim City is included inthe INSIDER for your convenience.

As many of you know, last year ourown ISMICS journal INNOVATIONSreceived recognition by the NationalLibrary of Medicine and be included inPubMed/MEDLINE. As the journal is nowindexed, all presenters at the ISMICSAnnual Meeting are expected to submittheir work to the journal, and we areoffering both a pre-Meeting Best Manu-script as well as a post-Meeting BestManuscript cash award. The journal iscontinuing to grow under the efforts of ourEditor in Chief, Dr. Ralph Damiano, and ourManaging Editor, Carol Blasberg. If youhave any questions about your submissionto INNOVATIONS, please see either ofthem while you are here in Prague.

While ISMICS has always had a veryactive Board of Directors, ScientificProgram Committee and NominatingCommittee, through the years othercommittee activity was sporadic. Thisyear we have had several very engagedcommittees, focused on Membership,Electronic Content and Technology, andInvestments. Each of these committeeshad participated in conference calls,taken action, and presented reports andrecommendations to the Board ofDirectors. Sincere thanks to the Chairsand committee members for yourcommitment to moving ISMICS forwardand offering your time and insight.

ISMICS also remains committed tobeing an inclusive and welcoming society.We hope that many of our non-memberattendees here in Prague will makeapplication to join the Society while youare here. We have many memberswilling to sponsor new members, andapplication can be made online orthrough the paper applications we willhave with us onsite. Please visit theRegistration Desk and make applicationto ISMICS today!

Each year as a write this message, Ireflect on what an honor it is for me to

serve as your Executive Director. I thinkof the many Presidents I have had theprivilege to work with over the years, andhow grateful I am that you remainengaged and involved with ISMICS. I amalways impressed by the commitment ofthe Board of Directors, and your willing-ness to give so freely of your time to ourSociety. I sincerely thank Dr. AlanMenkis, this year’s President, for yourstewardship of ISMICS over the pastyear, as well as our many talks andmeetings in so many places around theworld over the past 12 months. It hasbeen an absolute pleasure.

While I am your Executive Director, Icould not do what I do for ISMICS withoutmy amazing team.

From weathering (literally) floods toplanning numerous events across andocean and continent, and then handlingjust about everything in between, theyhave simply been outstanding. I warmlythank EJ Weldon, Jillian West, AmandaCarignan, Stan Alger, YvonneGrunebaum, Meg Bowen, ElizabethChouinard, Adam Denhard, Rhonda Pratl,Kerri Natale and Lorraine O’Grady.

Wishing you and your guests a greatmeeting and wonderful time in Prague.

Aurelie

Not an ISMICS Member? Join TODAYJoin TODAYJoin TODAYJoin TODAYJoin TODAYISMICS is helping shape the future of less invasive cardiac, vascular and thoracic surgery on a global

basis. The mission of the Society is to lead and promote innovation and technological advancement incardiothoracic and cardiovascular surgery through scientific analysis and education. If you are here inPrague, you KNOW the value of ISMICS’ educational programs.

The Society has over 800 international members. Stop by the Registration Area and complete anapplication onsite. Current Members are available to serve as your sponsor.

For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Edwards, Edwards Lifesciences, the stylized E logo, Edwards SAPIEN, Edwards SAPIEN XT, EDWARDS INTUITY, SAPIEN, SAPIEN XT, ThruPort are trademarks of Edwards Lifesciences Corporation.

© 2013 Edwards Lifesciences Corporation. All rights reserved. E3722/05-13/GEN

THRUPORTSYSTEMS

EDWARDS INTUITYVALVE SYSTEM

Edwards Lifesciences Irvine, USA I Nyon, Switzerland I Tokyo, Japan I Singapore, Singapore I São Paulo, Brazil edwards.com

The Leader in the Science of Heart Valves

EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE